Koch Industries Inc. boosted its position in Danaher Corporation (NYSE:DHR) by 29,127.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,404,665 shares of the conglomerate’s stock after buying an additional 1,399,859 shares during the quarter. Danaher Corporation accounts for approximately 0.4% of Koch Industries Inc.’s holdings, making the stock its 9th biggest holding. Koch Industries Inc. owned about 0.20% of Danaher Corporation worth $1,388,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. GQG Partners LLC acquired a new position in Danaher Corporation in the 2nd quarter worth $101,000. Proficio Capital Partners LLC raised its stake in shares of Danaher Corporation by 92.3% in the 1st quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock valued at $105,000 after purchasing an additional 598 shares in the last quarter. Monetary Management Group Inc. raised its stake in shares of Danaher Corporation by 10.7% in the 2nd quarter. Monetary Management Group Inc. now owns 1,550 shares of the conglomerate’s stock valued at $131,000 after purchasing an additional 150 shares in the last quarter. Acrospire Investment Management LLC raised its stake in shares of Danaher Corporation by 185.5% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock valued at $143,000 after purchasing an additional 1,100 shares in the last quarter. Finally, ClariVest Asset Management LLC acquired a new stake in shares of Danaher Corporation in the 1st quarter valued at about $157,000. Hedge funds and other institutional investors own 75.61% of the company’s stock.

Danaher Corporation (NYSE DHR) opened at $93.13 on Monday. Danaher Corporation has a 1 year low of $76.27 and a 1 year high of $93.16. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42. The company has a market cap of $64,778.23, a PE ratio of 23.94, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, topping the consensus estimate of $0.95 by $0.05. Danaher Corporation had a net margin of 13.36% and a return on equity of 11.29%. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same quarter in the prior year, the firm earned $0.87 EPS. Danaher Corporation’s quarterly revenue was up 9.6% on a year-over-year basis. sell-side analysts forecast that Danaher Corporation will post 3.99 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were given a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 16.52%.

In other news, insider William King sold 43,688 shares of the stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the transaction, the insider now directly owns 45,748 shares in the company, valued at $3,790,679.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the transaction, the chief executive officer now owns 271,737 shares of the company’s stock, valued at $25,173,715.68. The disclosure for this sale can be found here. In the last 90 days, insiders sold 279,628 shares of company stock valued at $25,304,394. 12.20% of the stock is owned by insiders.

TRADEMARK VIOLATION NOTICE: “Danaher Corporation (DHR) is Koch Industries Inc.’s 9th Largest Position” was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/danaher-corporation-dhr-is-koch-industries-inc-s-9th-largest-position/1682513.html.

A number of brokerages have recently issued reports on DHR. Robert W. Baird upped their target price on shares of Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Morgan Stanley upped their target price on shares of Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research note on Friday, October 20th. Credit Suisse Group upped their target price on shares of Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research note on Friday, October 20th. Zacks Investment Research upgraded shares of Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price on the stock in a research note on Thursday, October 5th. Finally, J P Morgan Chase & Co restated an “overweight” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, September 8th. One research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $93.31.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.